Treasurer of the State of North Carolina Invests $6.39 Million in Revvity, Inc. (NYSE:RVTY)

Treasurer of the State of North Carolina bought a new stake in Revvity, Inc. (NYSE:RVTYFree Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 58,453 shares of the company’s stock, valued at approximately $6,389,000.

Several other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. acquired a new position in shares of Revvity during the third quarter valued at about $1,579,487,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Revvity in the 4th quarter valued at $188,368,000. Norges Bank bought a new stake in Revvity in the fourth quarter valued at $129,483,000. Dimensional Fund Advisors LP bought a new stake in Revvity in the fourth quarter valued at $112,037,000. Finally, Ceredex Value Advisors LLC acquired a new position in Revvity during the fourth quarter worth $108,353,000. 86.65% of the stock is owned by institutional investors.

Revvity Stock Performance

Shares of NYSE:RVTY opened at $109.26 on Monday. The stock has a market capitalization of $13.48 billion, a P/E ratio of 90.30, a P/E/G ratio of 2.84 and a beta of 1.08. The company has a current ratio of 2.23, a quick ratio of 1.92 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 1-year low of $79.50 and a 1-year high of $131.96. The business has a 50-day moving average price of $105.36 and a two-hundred day moving average price of $103.80.

Revvity (NYSE:RVTYGet Free Report) last announced its quarterly earnings data on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.04. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The business had revenue of $649.90 million for the quarter, compared to analyst estimates of $646.83 million. During the same period in the prior year, the business posted $1.01 earnings per share. Revvity’s revenue was down 3.7% compared to the same quarter last year. Equities analysts predict that Revvity, Inc. will post 4.66 earnings per share for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be issued a $0.07 dividend. The ex-dividend date is Friday, July 19th. This represents a $0.28 dividend on an annualized basis and a yield of 0.26%. Revvity’s dividend payout ratio is presently 23.14%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Robert W. Baird upped their target price on shares of Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a report on Tuesday, April 30th. TD Cowen upped their price objective on shares of Revvity from $123.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, April 30th. Six research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from, the stock presently has an average rating of “Moderate Buy” and an average price target of $118.17.

Read Our Latest Report on Revvity

Revvity Profile

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Articles

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with's FREE daily email newsletter.